|
|
||||||||
From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Abstract
The synthetic terpolymer of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) not only fails to elicit a GAT-specific antibody response in nonresponder mice, but also prior injection of GAT specifically decreases the ability of nonresponder mice to develop a GAT-specific antibody response to a subsequent challenge with GAT-MBSA. This inhibition is mediated by GAT-specific suppressor T cells. Further, a suppressive factor can be extracted from lymphoid cells of GAT-primed nonresponder mice that inhibits the development of primary GAT-specific antibody responses to GAT-MBSA and to GAT-PRBC by normal syngeneic mice. The suppressive activity is dose-dependent and absorbed by GAT-Sepharose, but not by BSA-Sepharose. The suppressive activity elutes from a G-100 Sephadex column in the same fraction as ovalbumin, suggesting its m.w. is approximately 45,000 daltons.
Footnotes
1 This investigation was supported by United States Public Health Service Grants AI-09920 and AI-09897 from the National Institute of Allergy and Infectious Diseases.
2 Recipient of United States Public Health Service Research Career Development Award 5K4-AI-70173 from the National Institute of Allergy and Infectious Disease.
This article has been cited by other articles:
![]() |
W. Paul and B Benacerraf Functional specificity of thymus- dependent lymphocytes Science, March 25, 1977; 195(4284): 1293 - 1300. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |